Saluseq Evo

Description:
Salus EVO High Throughput Sequencer is a high-performance NGS sequencing platform designed for large-scale genomic analysis requiring high capacity, speed and flexibility. The system combines high data output with parallel sequencing capability.

Salus EVO supports sequencing capacity up to 3000M reads per run and can operate with up to two sequencing chips simultaneously. Depending on the selected Sequencing Reagent Set configuration, the system provides data output from 112.5 Gb up to 1.8 Tb per run with sequencing times approximately 9.5 to 24 hours.

The platform is designed for demanding genomic applications including whole exome sequencing (WES), whole genome sequencing (WGS), single cell sequencing and spatial transcriptomics.

Features:

• high-throughput NGS sequencing system
• supports up to two sequencing chips simultaneously
• capacity up to 3000M reads/run
• data output up to 1.8 Tb/run
• rapid generation of large sequencing datasets
• supports SE75, PE100 and PE150 reads
• designed for large-scale genomic projects
• flexible Sequencing Reagent Set configurations
• optimized for high-capacity sequencing applications

Instrument Specification:

Applications:

• Whole Exome Sequencing (WES)
• Whole Genome Sequencing (WGS)
• Single Cell Sequencing
• Spatial Transcriptomics
• large-scale genomic projects
• molecular biology research
• advanced sequencing analysis

Overview of sequencing reagent kits for the Salus EVO high-throughput platform. The table 1 summarizes available reagent sets (1500M and 3000M), read lengths, data output per one or two chips, estimated run time and Q30 quality performance. Salus EVO supports simultaneous operation of up to two chips for maximum throughput.

Overview of the recommended Salus EVO sequencing capacity for different NGS applications. The table 2 shows the estimated number of samples per run for each reagent configuration (1×1500M, 2×1500M, 1×3000M, 1500M + 3000M and 2×3000M), covering WES, WGS, WGBS, Single Cell, Large Panel and Spatial Transcriptomics.